Alexandra F. Dalton

Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

Jill M. Ferdinands, Suchitra Rao, Brian E. Dixon et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 466 citations · Full text

Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States

Nicholas P. Deputy, Joseph Deckert, Anna N. Chard et al. · New England Journal of Medicine · 2023 · 288 citations · Full text

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022

Nicola P. Klein, Melissa S. Stockwell, Maria Demarco et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 192 citations · Full text

Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study — United States, August 19, 2022–March 31, 2023

Alexandra F. Dalton, Alpha Oumar Diallo, Anna N. Chard et al. · MMWR Morbidity and Mortality Weekly Report · 2023 · 170 citations · Full text

Long COVID and Significant Activity Limitation Among Adults, by Age — United States, June 1–13, 2022, to June 7–19, 2023

Nicole D. Ford, Douglas Slaughter, Deja Edwards et al. · MMWR Morbidity and Mortality Weekly Report · 2023 · 163 citations · Full text

Epidemiological Dynamic, Population Health Sciences, Covid-19 Epidemiology +19